Issuer · CIK 0002007191

TLX — Telix Pharmaceuticals Ltd

Recent filings

May 7, 2026·Form 4·Buy$499.6K
TLX/Telix Pharmaceuticals Ltd
Behrenbruch Christian · MD & Group CEO
68conviction

← Back to all filings